Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.86 BRL | -0.75% | -0.59% | -13.55% |
Mar. 04 | Barclays Downgrades Ambev to Equalweight From Overweight, Adjusts Price Target to $3 From $3.50 | MT |
Feb. 29 | Transcript : Ambev S.A., Q4 2023 Earnings Call, Feb 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.55% | 36.25B | |
-4.31% | 118B | |
+384.45% | 67.41B | |
+7.46% | 47.48B | |
-0.98% | 22.85B | |
+10.70% | 18.79B | |
+5.40% | 17.92B | |
-27.91% | 17.46B | |
+2.34% | 13.85B | |
+4.13% | 13.7B |
- Stock Market
- Equities
- ABEV3 Stock
- News Ambev S.A.
- Ambev S A : Morgan Stanley Downgrades Ambev to Underweight from Equalweight